Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,225 | 14 | 80.1% |
| Travel and Lodging | $3,290 | 8 | 16.2% |
| Food and Beverage | $729.23 | 13 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $16,240 | 24 | $0 (2020) |
| TESARO, Inc. | $2,830 | 8 | $0 (2019) |
| AbbVie, Inc. | $1,149 | 2 | $0 (2019) |
| Intuitive Surgical, Inc. | $25.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $3,225 | 2 | Merck Sharp & Dohme Corporation ($3,225) |
| 2019 | $8,325 | 19 | Merck Sharp & Dohme Corporation ($5,397) |
| 2018 | $450.00 | 2 | TESARO, Inc. ($450.00) |
| 2017 | $8,243 | 12 | Merck Sharp & Dohme Corporation ($7,618) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2020 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2020 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Consulting Fee | Cash or cash equivalent | $1,225.00 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/06/2019 | TESARO, Inc. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $123.17 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $114.68 | General |
| 05/31/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 05/02/2019 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 03/16/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $48.94 | General |
| 02/28/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $115.50 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | Cash or cash equivalent | $53.42 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $115.50 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $1,828.13 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | Cash or cash equivalent | $134.11 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $115.50 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2018 | TESARO, Inc. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 06/01/2018 | TESARO, Inc. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 12/27/2017 | TESARO, Inc. | ZEJULA (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 33 | 46 | $12,450 | $1,230 |
| 2020 | 4 | 89 | 158 | $70,855 | $8,551 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 32 | $7,200 | $800.16 | 11.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 14 | $5,250 | $430.31 | 8.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 88 | $33,000 | $3,982 | 12.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 37 | $20,350 | $2,312 | 11.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 12 | 12 | $12,780 | $1,769 | 13.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 21 | $4,725 | $487.73 | 10.3% |
About Dr. Douglas Levine, MD
Dr. Douglas Levine, MD is a Obstetrics & Gynecology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194700831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Levine, MD has received a total of $20,244 in payments from pharmaceutical and medical device companies, with $3,225 received in 2020. These payments were reported across 35 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($16,225).
As a Medicare-enrolled provider, Levine has provided services to 122 Medicare beneficiaries, totaling 204 services with total Medicare billing of $9,781. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecologic Oncology
- Location New York, NY
- Active Since 12/14/2005
- Last Updated 10/31/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1194700831
Products in Payments
- MK-7339 (Drug) $6,507
- ZEJULA (Drug) $2,580
- Da Vinci Surgical System (Device) $25.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in New York
Mary Polan, M.d, M.D
Obstetrics & Gynecology — Payments: $2.3M
Steven Goldstein, Md, MD
Obstetrics & Gynecology — Payments: $831,948
Veronica Lerner, Md, MD
Obstetrics & Gynecology — Payments: $233,429
Jian Qun Huang, M.d, M.D
Obstetrics & Gynecology — Payments: $212,396
Carolyn Westhoff, M.d, M.D
Obstetrics & Gynecology — Payments: $185,820
Dr. Lisa Eng, D.o, D.O
Obstetrics & Gynecology — Payments: $178,012